Ignite Creation Date:
2024-05-06 @ 7:12 PM
Last Modification Date:
2024-10-26 @ 3:02 PM
Study NCT ID:
NCT05927857
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-07-03
First Post:
2023-06-14
Brief Title:
Ramucirumab Cyramza Nal-IRI ONIVYDE and TrifluridineTipiracil Lonsurf in Second Line Metastatic Gastric Cancer
Sponsor:
National Health Research Institutes Taiwan
Organization:
National Health Research Institutes Taiwan
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-06-14
First Submit QC Date:
June 25 2023
Study First Post Date:
2023-07-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-25
Last Update Post Date:
2023-07-03
Last Update Post Date Type:
ACTUAL